Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sphingosine 1 Phosphate

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop (S1P)
    Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop (S1P)

    11 Mar 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bridge-medicines-enters-agreement-with-weill-cornell-medicine-to-develop-a-novel-sphingosine-1-phosphate-s1p-receptor-modulator-300807907.html

    PR NEWSWIRE
    11 Mar 2019
    Share Share